This expansion supports Tenovi's broader suite of telemetry solutions designed for cardiometabolic populations, an area of growing focus for health plans and employer-sponsored programs. By enabling ...

DexCom focuses on continuous glucose monitoring systems, with a strong market position and global reach. Click here to read ...

Dexcom's growth in sensors and U.S. expansion is solid, but slowing revenue growth and high valuation limit upside. Click ...

Dexcom is recalling certain Dexcom G6, G7, ONE, and ONE+ glucose monitoring receivers because of a problem with the speaker that may cause it to fail to make an alert sound when blood sugar is dangero ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the launch of the fourth season of ...

US adults who want to measure their blood glucose levels using a wearable biosensor will soon be able to buy one over-the-counter (OTC) from Dexcom.

DexCom Inc. Annual stock financials by MarketWatch. View the latest DXCM financial statements, income statements and financial ratios.

Dexcom (Nasdaq:DXCM) has issued an update related to a recall for its continuous glucose monitor (CGM) components.